Â
Acumen Pharmaceuticals ABOS reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Acumen Pharmaceuticals missed estimated earnings by 4.17%, reporting an EPS of $-0.25 versus an estimate of $-0.24.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.06 which was followed by a 13.0% increase in the share price the next day.
Â
To track all earnings releases for Acumen Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.